SPF 20 UVA/UVB

Manufacturer
MULTALER ET CIE S.A.S.
Effective date
2018-01-02
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-02 01:05:31

Label at a glance#

ProductSPF 20 UVA/UVB
Active ingredientHOMOSALATE, OCTINOXATE, OCTISALATE, OXYBENZONE, AVOBENZONE, OCTOCRYLENE
Label structure2 sections

Label contents#

Full prescribing information#

DRUG FACTS

WARNINGS AND PRECAUTIONS SECTION

Active ingredients Purpose

Homosalate 10% {

Octinoxate 7.5% {

Octisalate 5% { Sunscreen

Oxybenzone 5% {

Avobenzone 3% {

Octocrylene 2.7% {

DESCRIPTION SECTION

SOLAR CARE

SPF 20 UVA/UVB

BROAD SPECTRUM

SPRAY SOLAIRE

Protection moyenne

aux polyphénols d'olive

SUNSCREEN SPRAY

Medium protection

with olive polyphenols

Spray solaire aux polyphénols d'olive.

Visage et corps. Protection moyenne

SPF 20

Sunscreen spray with olive polyphenols.

Face and body. Medium protection

SPF 20

Spray solar con polifenoles de oliva.

Cara y cuerpo. Proteccion media SPF 20

Sonnenspray mit Olivenpolyphenolen.

Gesicht und Körper. Mittlerer Schutz

SPF 20

Spray solare ai polifenoli de oliva. Viso e

corpo. Protezione media SPF 20

Zonnenspray met polyfenolen uit

olijven. Gelaat en lichaam. Gemiddelde

bescherming SPF 20

Spray solar à base de poefenois de

azeitona. Rosto e corpo. Protecçao

média SPF 20

Aide à prévenir les coups de soleil. Appliquer

généreusement avant toute exposition.

Ne pas pulvériser directement sur le visage.

Pulvériser sur les mains puis appliquer sur

le visage. Renouveler fréquemment et

généreusement l'application pour main-

tenir la protection, surtout après avoir

transpiré, avoir nagé ou s'être essuyé. Pour

les enfants de moins de 6 mois, consulter

un médecin.

Avertissement : Pour usage externe seule-

ment. Eviter tout contact avec les yeux. En

cas de contact, rincer abondamment.

Cesser d'utiliser et consulter un médecin

en cas d'irritations ou d'éruptions cutanées.

Tenir hors de la portée des enfants. En cas

d'absorption, consulter un médecin ou le

centre anti-poisons.

Recommandations : Eviter de trop vous

exposer aux heures les plus chaudes de la

journée. Ne restez pas trop longtemps au

soleil. même si vous utilisez un produit de

protection solaire. Protégez-vous avec un

chapeau, un t-shirt et des lunettes de soleil.

N'exposez pas les bébés et les jeunes

enfants directement au soleil. La surexpo-

sition au soleil est une menace sérieuse

pour la santé.

CONTIENT DE L'OXYBENZONE

NON COMEDOGENE

NON COMEDOGENIC

TOLERANCE TESTEE SOUS CONTROLE DERMATOLOGIQUE

TOLERANCE TESTED BY DERMATOLOGISTS

WARNINGS AND PRECAUTIONS SECTION

Uses • hels prevent sunburn.

Warnings

For external use only.

Do not use on damaged or broken skin.

Stop use and ask a doctor if rash occurs.

When using this product keep out of eyes.

Rinse with water to remove. When using this

product keep away from face to avoid

breathing it.

Keep out of reach of children. If swallowed,

get medical help or contact poison control

center right away.

Directions

• Spray liberally and spread evenly by hand

15 minutes before sun exposure.

• Do not spray directly into face. Spray on hands

then apply to face.

• Use a water resistant sunscreen if swimming or

sweating.

• Reapply at least every 2 hours.

• Children under 6 months : ask a doctor.

• Sun protection measures. Spending time in the

sun increases your risk of skin cancer and early

skin aging? To decrease this risk, regularly use a

sunscreen with a broad sprectrum SPF value of

15 or higher and other sun protection measures

including:

• limit time in the sun, especially from

10 a.m-2p.m

• wear long-sleeved shirts, pants, and

sunglasses.

Other information

• Protect this product from excessive heat and

direct sun.

INACTIVE INGREDIENT SECTION

Inactive ingredients Aqua/water/eau,

Cyclomethicone, C12-15 alkyl benzoate,

Glycerin, ppg-12/smdi copolymer, propylene

glycol dicaprylate/dicaprate, lauryl glucoside,

polyglyceryl-2 dipolyhydroxystearate,

dimethicone crosspolymer, tocopheryl acetate

(vit. E : 0.5%), phenoxyethanol, bisabolol,

Chlorphenesin, xanthan gum, acrylates/C10-30

alkyl acrylate crosspolymer, tetrasodium edta,

lavandula angustifolia (lavender) oil,

biosaccharide gum-1, pelargonium graveolens

(geranium) leaf oil, manganese gluconate,

rosmarinus officinalis (rosemary) leaf oil,

cupressus sempervirens (cypress) oil, thymus

vulgaris (thyme) flower/leaf oil, citric acid,

sodium hydroxide, olea europaea (olive) fruit

extract, methylisothiazolinone, linalool *,

citronellol*, geraniol*, limonene*.

*composants naturels d'huile essentielle - natural

components of essentials oils.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ETUI SPF20 UVA UVBETUI SPF20 UVA UVB

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOX6
HOMOSALATEACTIVE INGREDIENTV06SV4M95S6
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD516
OCTISALATEACTIVE INGREDIENT4X49Y0596W6
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WM6
OXYBENZONEACTIVE INGREDIENT95OOS7VE0Y6
AVOBENZONEACTIVE MOIETYG63QQF2NOX6
HOMOSALATEACTIVE MOIETYV06SV4M95S6
OCTINOXATEACTIVE MOIETY4Y5P7MUD516
OCTISALATEACTIVE MOIETY4X49Y0596W6
OCTOCRYLENEACTIVE MOIETY5A68WGF6WM6
OXYBENZONEACTIVE MOIETY95OOS7VE0Y6
.ALPHA.-BISABOLOL, (+/-)-INACTIVE INGREDIENT36HQN158VC6
ALPHA-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L06
BIOSACCHARIDE GUM-1INACTIVE INGREDIENTBB4PU4V09H6
C12-15 ALKYL BENZOATEINACTIVE INGREDIENTA9EJ3J61HQ6
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)INACTIVE INGREDIENT71DD5V995L6
CHLORPHENESININACTIVE INGREDIENTI670DAL4SZ6
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP6
CUPRESSUS SEMPERVIRENS LEAF OILINACTIVE INGREDIENTM7QUY89S4O6
CYCLOMETHICONEINACTIVE INGREDIENTNMQ347994Z6
DIMETHICONE/DIENE DIMETHICONE CROSSPOLYMERINACTIVE INGREDIENTRSA9I561OK6
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LU6
GLYCERININACTIVE INGREDIENTPDC6A3C0OX6
LAURYL GLUCOSIDEINACTIVE INGREDIENT76LN7P7UCU6
LAVANDULA ANGUSTIFOLIA WHOLEINACTIVE INGREDIENT51217XIL5L6
MANGANESE GLUCONATEINACTIVE INGREDIENT9YY2F980SV6
METHYLISOTHIAZOLINONEINACTIVE INGREDIENT229D0E1QFA6
OLEA EUROPAEA WHOLEINACTIVE INGREDIENT769297N5OK6
PEG-8/SMDI COPOLYMERINACTIVE INGREDIENTCCX72L6NY66
PELARGONIUM GRAVEOLENS FLOWER OILINACTIVE INGREDIENT3K0J1S7QGC6
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T6
POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATEINACTIVE INGREDIENT9229XJ4V126
PROPYLENE GLYCOL DICAPRYLATE/DICAPRATEINACTIVE INGREDIENTO4446S9CRA6
ROSMARINUS OFFICINALIS WHOLEINACTIVE INGREDIENTEA3289138M6
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I6
THYMUS VULGARIS WHOLEINACTIVE INGREDIENT8L72OKJ7II6
WATERINACTIVE INGREDIENT059QF0KO0R6
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 37 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51191-204651191-2046-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 35 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 394 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / PERINEURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ALPHA-TOCOPHEROL ACETATE.ALPHA.-TOCOPHEROL ACETATE9E8X80D2L0CAPSULE / ORAL2 mgExact identifier — unii candidate
3 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPCAPSULE / ORAL238 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / RESPIRATORY (INHALATION)8 %w/vExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / EPIDURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IAEROSOL, METERED / RESPIRATORY (INHALATION)ADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS385 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IGEL, METERED / TRANSDERMAL350 mgExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / BUCCALNAExact identifier — unii candidate
88 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRACARDIAC1.05 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
CYCLOMETHICONECYCLOMETHICONENMQ347994ZCREAM / TOPICAL13 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDROPS / NASAL10 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION/ DROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEELOTION / TOPICAL0.3 %w/vExact identifier — unii candidate
29 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRA-ARTERIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRASPINALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPLIQUID / ORAL114 mgExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / INTRAOCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ILOTION, AUGMENTED / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYSTEM / IONTOPHORESIS168.1 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET / ORAL10 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS78.36 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / NASAL20 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / EXTRACORPOREALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR38 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOAP / TOPICAL0.5 %w/wExact identifier — unii candidate
88 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEAEROSOL, FOAM / TOPICAL0.27 %w/wExact identifier — unii candidate
29 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / AURICULAR (OTIC)0.2 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAVENOUS78 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYRUP / ORAL16734 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISHAMPOO / TOPICAL3 mgExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION, CONCENTRATE / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IINJECTION / INTRACARDIACADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXMOUTHWASH / BUCCAL100 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / VAGINAL60 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ICREAM / TOPICAL69 mgExact identifier — unii candidate
174 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEELOZENGE / ORAL1264 mgExact identifier — unii candidate
29 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET, EXTENDED RELEASE / ORAL13 mgExact identifier — unii candidate
174 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS225 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET / ORAL42 mgExact identifier — unii candidate
75 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INFILTRATION0.02 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET, FILM COATED / ORAL0.08 mgExact identifier — unii candidate
29 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32IPOWDER, FOR SUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET / ORAL914 mgExact identifier — unii candidate
88 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEFILM, SOLUBLE / ORAL1 mgExact identifier — unii candidate
29 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPLOTION / TOPICAL0.85 %w/wExact identifier — unii candidate
88 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM / TOPICAL57 mgExact identifier — unii candidate
6 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSPRAY / NASAL9 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / ORAL446 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPELIXIR / ORAL100 mg/5mlExact identifier — unii candidate
88 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUSOAP / TOPICAL0.12 %w/wExact identifier — unii candidate
12 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ITABLET, DELAYED RELEASE / ORAL4 mgExact identifier — unii candidate
174 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / INTRAVENOUS10 mgExact identifier — unii candidate
88 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEGEL / TOPICAL58 mgExact identifier — unii candidate
29 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c987df86-d3f7-43b9-ab27-f6a183192595933d7899-3c09-4de8-8039-bf25e162c44b2019-12-12WarningsExact identifier
spl set id: 933d7899-3c09-4de8-8039-bf25e162c44b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.